Bristol-Myers Squibb Co.
BMY
62.33−0.58 (−0.92%)Nov 12, 7:45 PM ET
Key stats
- Open
- 63.80
- Day high
- 64.12
- Day low
- 62.31
- Previous close
- 62.91
- Volume
- 9.39M
- VWAP
- 62.67
- 52-week high
- 68.64
- 52-week low
- 45.27
- Market cap
- 128.59B
- Shares out
- 2.04B
- Employees
- 32,500
- Listed
- 1952
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
PHARMACEUTICAL PREPARATIONS · PRINCETON, NJ · bms.com
Options · expiring Nov 13
Nov 12, 4:00 PM ET- Call open interest
- 8.5K
- Put open interest
- 23.6K
- Put/call
- 2.77
- At-the-money IV
- 36.4%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 60 put | 0.04 | Nov 12, 3:44 PM | 1.5K | 7.5K | 61.0% |
| 54 put | 0.01 | Nov 9, 11:26 AM | 126 | 216 | 173.9% |
| 62 put | 0.37 | Nov 12, 3:59 PM | 97 | 2.2K | 46.6% |
| 65 call | 0.02 | Nov 12, 3:53 PM | 90 | 610 | 41.9% |
| 56 put | 0.03 | Nov 9, 3:42 PM | 50 | 3.2K | 153.1% |
| 63 call | 0.42 | Nov 12, 3:45 PM | 47 | 2.1K | 40.6% |
Quarterly results
Massive · Jul 30, 2026| Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | Q3 2025 to Sep 30, 2025 | |
|---|---|---|---|---|
| Revenue | $12.97B | $11.49B | $12.50B | $12.22B |
| Gross profit | $9.25B | $8.07B | $8.40B | $8.79B |
| Operating income | $4.03B | $3.27B | $1.42B | $3.01B |
| Net income | $3.32B | $2.68B | $1.09B | $2.20B |
| Diluted EPS | 1.62 | 1.31 | 0.53 | 1.08 |
| Operating cash flow | $3.39B | $1.10B | $1.97B | $6.31B |
| Assets | $87.63B | $86.48B | $90.04B | $96.89B |
| Liabilities | $65.31B | $66.37B | $71.53B | $78.29B |
| Equity | $22.32B | $20.10B | $18.51B | $18.60B |
Technicals
Massive · Nov 12, 2026- 50-day average61.99
- 200-day average60.30
- RSI (14 days)51.5
Short interest
Massive · Oct 30, 2026- Oct 30, 202646.85M shares · 4.2 days to cover
- Oct 15, 202649.95M shares · 3.6 days to cover
- Sep 30, 202645.85M shares · 3.0 days to cover
- Sep 15, 202641.97M shares · 5.8 days to cover
Dividends
Massive · Oct 2, 2026- Ex Oct 2, 2026, paid Nov 2, 20260.6300 · 4 a year
- Ex Jul 2, 2026, paid Aug 3, 20260.6300 · 4 a year
- Ex Apr 2, 2026, paid May 1, 20260.6300 · 4 a year
- Ex Jan 2, 2026, paid Feb 2, 20260.6300 · 4 a year
- Ex Oct 3, 2025, paid Nov 3, 20250.6200 · 4 a year
- Ex Jul 3, 2025, paid Aug 1, 20250.6200 · 4 a year
- Ex Apr 4, 2025, paid May 1, 20250.6200 · 4 a year
- Ex Jan 3, 2025, paid Feb 3, 20250.6200 · 4 a year
Related companies
MassiveNews coverage
No stories about Bristol-Myers Squibb Co. right now.